Home > World > GSK – INTERIM EFFICACY AND SAFETY DATA FOR BLENREP AS A FIRST LINE TREATMENT ARE EXPECTED IN EARLY 2028

GSK – INTERIM EFFICACY AND SAFETY DATA FOR BLENREP AS A FIRST LINE TREATMENT ARE EXPECTED IN EARLY 2028

Last Updated: October 24, 2025 01:32:11 IST

GSK – INTERIM EFFICACY AND SAFETY DATA FOR BLENREP AS A FIRST LINE TREATMENT ARE EXPECTED IN EARLY 2028

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

Most Popular

The Sunday Guardian is India’s fastest
growing News channel and enjoy highest
viewership and highest time spent amongst
educated urban Indians.

The Sunday Guardian is India’s fastest growing News channel and enjoy highest viewership and highest time spent amongst educated urban Indians.

© Copyright ITV Network Ltd 2025. All right reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?